These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 22212769)

  • 1. Oleanolic Acids Inhibit Vascular Endothelial Growth Factor Receptor 2 Signaling in Endothelial Cells: Implication for Anti-Angiogenic Therapy.
    Lee DH; Lee J; Jeon J; Kim KJ; Yun JH; Jeong HS; Lee EH; Koh YJ; Cho CH
    Mol Cells; 2018 Aug; 41(8):771-780. PubMed ID: 30037214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel poly-naphthol compound ST104P suppresses angiogenesis by attenuating matrix metalloproteinase-2 expression in endothelial cells.
    Ma YL; Lin SW; Fang HC; Chou KJ; Bee YS; Chu TH; Chang MC; Weng WT; Wu CY; Cho CL; Tai MH
    Int J Mol Sci; 2014 Sep; 15(9):16611-27. PubMed ID: 25244013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying Angiogenesis Using Matrigel In Vitro and In Vivo.
    Kanugula AK; Adapala RK; Guarino BD; Bhavnani N; Dudipala H; Paruchuri S; Thodeti CK
    Methods Mol Biol; 2024; 2711():105-116. PubMed ID: 37776452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway.
    Hsu SP; Ho PY; Juan SH; Liang YC; Lee WS
    Cell Mol Life Sci; 2008 Nov; 65(23):3839-50. PubMed ID: 18850315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway.
    Lu H; Zhou X; Kwok HH; Dong M; Liu Z; Poon PY; Luan X; Ngok-Shun Wong R
    Front Pharmacol; 2017; 8():783. PubMed ID: 29180961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.
    Leopold JA; Dam A; Maron BA; Scribner AW; Liao R; Handy DE; Stanton RC; Pitt B; Loscalzo J
    Nat Med; 2007 Feb; 13(2):189-97. PubMed ID: 17273168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone promotes cardiac endothelial cell proliferation in vivo.
    Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Clément K; Farman N; Jaisser F; Messaoudi S
    J Am Heart Assoc; 2015 Jan; 4(1):e001266. PubMed ID: 25564371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.
    Hermawan A; Putri H
    BMC Genom Data; 2022 Sep; 23(1):72. PubMed ID: 36114448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs and Angiogenesis-Implications in Pathology.
    Wagner N; Wagner KD
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal protein restriction differentially alters the expression of AQP1, AQP9 and VEGFr-2 in the epididymis of rat offspring.
    Cavariani MM; de Mello Santos T; Pereira DN; de Almeida Chuffa LG; Felipe Pinheiro PF; Scarano WR; Domeniconi RF
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.
    Zhao M; Mantel I; Gelize E; Li X; Xie X; Arboleda A; Seminel M; Levy-Boukris R; Dernigoghossian M; Prunotto A; Andrieu-Soler C; Rivolta C; Canonica J; Naud MC; Lechner S; Farman N; Bravo-Osuna I; Herrero-Vanrell R; Jaisser F; Behar-Cohen F
    Nat Commun; 2019 Jan; 10(1):369. PubMed ID: 30664640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.
    Brown SM; Meuth AI; Davis JW; Rector RS; Bender SB
    Pharmacol Res; 2018 Aug; 134():100-108. PubMed ID: 29870805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of
    Penas FN; Carta D; Dmytrenko G; Mirkin GA; Modenutti CP; Cevey ÁC; Rada MJ; Ferlin MG; Sales ME; Goren NB
    Front Immunol; 2017; 8():1738. PubMed ID: 29312293
    [No Abstract]   [Full Text] [Related]  

  • 14. PPAR Gamma and Angiogenesis: Endothelial Cells Perspective.
    Kotlinowski J; Jozkowicz A
    J Diabetes Res; 2016; 2016():8492353. PubMed ID: 28053991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.
    Kotlinowski J; Grochot-Przeczek A; Taha H; Kozakowska M; Pilecki B; Skrzypek K; Bartelik A; Derlacz R; Horrevoets AJ; Pap A; Nagy L; Dulak J; Jozkowicz A
    Cardiovasc Diabetol; 2014 Nov; 13():150. PubMed ID: 25361524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decrease of mineralcorticoid receptor drives angiogenic pathways in colorectal cancer.
    Tiberio L; Nascimbeni R; Villanacci V; Casella C; Fra A; Vezzoli V; Furlan L; Meyer G; Parrinello G; Baroni MD; Salerni B; Schiaffonati L
    PLoS One; 2013; 8(3):e59410. PubMed ID: 23555666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.
    Bhattacharya D; Singh MK; Chaudhuri S; Acharya S; Basu AK; Chaudhuri S
    J Neurooncol; 2013 May; 113(1):13-25. PubMed ID: 23471571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma.
    Fujii M; Inoki I; Saga M; Morikawa N; Arakawa K; Inaba S; Yoshioka K; Konoshita T; Miyamori I
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):145-52. PubMed ID: 22212769
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.